# ANI Pharmaceuticals Canada, Inc. – FDA Inspection, Feb 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/ani-pharmaceuticals-canada-inc/7924e187-3fd5-44ff-aeb4-09be81c25b48
Source feed: FDA_Inspections

> FDA inspection 1197890 of ANI Pharmaceuticals Canada, Inc., February 17, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197890
- Company Name: ANI Pharmaceuticals Canada, Inc.
- Inspection Date: 2023-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1096666 - 2019-06-07](https://www.keypedia.com/records/fda_inspections/ani-pharmaceuticals-canada-inc/7612d98c-325a-4a89-9b8c-fa5716b8fedc)
- [FDA Inspection 997351 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/ani-pharmaceuticals-canada-inc/22d503db-17e6-4e2e-9793-da50a16b530c)
- FDA Inspection 866138 - 2014-01-24
- [FDA Inspection 635624 - 2009-12-18](https://www.keypedia.com/records/fda_inspections/ani-pharmaceuticals-canada-inc/73033277-4374-4eb5-94a3-cdfadf30ffc2)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)
- [Sena G. Dissmeyer](https://www.keypedia.com/people/sena-g-dissmeyer/4dbb1255-95e4-402b-8bb3-75c4f7940c13)

Company: https://www.keypedia.com/companies/ani-pharmaceuticals-canada-inc/0f57ea01-9f34-4a4f-a2b9-4df6eb53a726

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c